Advertisement
Screener

CAREDX, INC. (CDNA) Net Cash Provided by (Used in) Operating Activities, Continuing Operations

2.8 / 5 stars · 68/120 Roast Me

CAREDX, INC. Net Cash Provided by (Used in) Operating Activities, Continuing Operations

CAREDX, INC. (CDNA) reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$4.52 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.

Discontinued › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2018-05-10

  • CAREDX, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2018-03-31 was -$4.52M.
  • CAREDX, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-12-31 was -$2.15M.
  • CAREDX, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-09-30 was -$2.22M.
  • CAREDX, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-06-30 was -$3.20M.
  • CAREDX, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2017 was -$14.31M.
  • CAREDX, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2016 was -$16.52M.
  • CAREDX, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was -$9.75M.
  • CAREDX, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was -$3.35M.
Period endNet Cash Provided by (Used in) Operating Activities, Continuing Operations 3 monthNet Cash Provided by (Used in) Operating Activities, Continuing Operations 6 monthNet Cash Provided by (Used in) Operating Activities, Continuing Operations 9 monthNet Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month
2018-03-31-$4.52M
10-Q · filed 2018-05-10
-$6.67M
derived: sum of 2 quarters · filed 2018-05-10
-$8.89M
derived: sum of 3 quarters · filed 2018-05-10
-$12.08M
derived: sum of 4 quarters · filed 2018-05-10
2017-12-31-$2.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22
-$4.37M
derived: sum of 2 quarters · filed 2018-03-22
-$7.57M
derived: sum of 3 quarters · filed 2018-03-22
-$14.31M
10-K · filed 2018-03-22
2017-09-30-$2.22M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
-$5.42M
derived: sum of 2 quarters · filed 2017-11-09
-$12.16M
10-Q · filed 2017-11-09
-$15.22M
derived: sum of 4 quarters · filed 2018-05-10
2017-06-30-$3.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11
-$9.94M
10-Q · filed 2017-08-11
-$13.00M
derived: sum of 3 quarters · filed 2018-05-10
-$14.20M
derived: sum of 4 quarters · filed 2018-05-10
2017-03-31-$6.74M
10-Q · filed 2018-05-10
-$9.80M
derived: sum of 2 quarters · filed 2018-05-10
-$11.01M
derived: sum of 3 quarters · filed 2018-05-10
-$17.07M
derived: sum of 4 quarters · filed 2018-05-10
2016-12-31-$3.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22
-$4.26M
derived: sum of 2 quarters · filed 2018-03-22
-$10.33M
derived: sum of 3 quarters · filed 2018-03-22
-$16.52M
10-K · filed 2018-03-22
2016-09-30-$1.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
-$7.27M
derived: sum of 2 quarters · filed 2017-11-09
-$13.46M
10-Q · filed 2017-11-09
-$17.44M
derived: sum of 4 quarters · filed 2018-03-22
2016-06-30-$6.07M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11
-$12.26M
10-Q · filed 2017-08-11
-$16.23M
derived: sum of 3 quarters · filed 2018-03-22
-$19.26M
derived: sum of 4 quarters · filed 2018-03-22
2016-03-31-$6.19M
10-Q · filed 2017-06-09
-$10.17M
derived: sum of 2 quarters · filed 2018-03-22
-$13.20M
derived: sum of 3 quarters · filed 2018-03-22
-$14.93M
derived: sum of 4 quarters · filed 2018-03-22
2015-12-31-$3.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22
-$7.00M
derived: sum of 2 quarters · filed 2018-03-22
-$8.74M
derived: sum of 3 quarters · filed 2018-03-22
-$9.75M
10-K · filed 2018-03-22
2015-09-30-$3.03M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14
-$4.76M
derived: sum of 2 quarters · filed 2016-11-14
-$5.78M
10-Q · filed 2016-11-14
-$6.50M
derived: sum of 4 quarters · filed 2017-04-21
2015-06-30-$1.73M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-22
-$2.75M
10-Q · filed 2016-08-22
-$3.47M
derived: sum of 3 quarters · filed 2017-04-21
-$7.13M
derived: sum of 4 quarters · filed 2017-04-21
2015-03-31-$1.01M
10-Q · filed 2016-05-16
-$1.74M
derived: sum of 2 quarters · filed 2017-04-21
-$5.40M
derived: sum of 3 quarters · filed 2017-04-21
-$4.54M
derived: sum of 4 quarters · filed 2017-04-21
2014-12-31-$722.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-21
-$4.38M
derived: sum of 2 quarters · filed 2017-04-21
-$3.53M
derived: sum of 3 quarters · filed 2017-04-21
-$3.35M
10-K · filed 2017-04-21
2014-09-30-$3.66M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13
-$2.81M
derived: sum of 2 quarters · filed 2015-11-13
-$2.63M
10-Q · filed 2015-11-13
-$3.55M
derived: sum of 4 quarters · filed 2016-03-29
2014-06-30$853.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-28
$1.03M
10-Q · filed 2015-08-12
$115.00K
derived: sum of 3 quarters · filed 2016-03-29
$1.76M
derived: sum of 4 quarters · filed 2016-03-29
2014-03-31$180.00K
10-Q · filed 2015-05-14
-$738.00K
derived: sum of 2 quarters · filed 2016-03-29
$911.00K
derived: sum of 3 quarters · filed 2016-03-29
2013-12-31-$918.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29
$731.00K
derived: sum of 2 quarters · filed 2016-03-29
-$546.00K
10-K · filed 2016-03-29
2013-09-30$1.65M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14
$372.00K
10-Q · filed 2014-11-14
2013-06-30-$1.28M
10-Q · filed 2014-08-28
2012-12-31-$1.78M
10-K · filed 2015-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
Celcuity Inc. (CELC)United States$3.887B-22.62
VERACYTE, INC. (VCYT)United States$3.904B41.21
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
GRAIL, Inc. (GRAL)United States$5.591B-7.78
RadNet, Inc. (RDNT)United States$5.611B-229.65
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
BIODESIX INC (BDSX)United States$0.312B